Videos / Enteric coated risedronate 35mg for the treatment of osteoporosis
In this Product Explainer, Endocrinologist Prof Ego Seeman explains the role of enteric coated risedronate 35mg for the treatment of osteoporosis (5 mins).

Non-Hormonal Options for Menopausal Symptoms

Holter Monitoring in GP – Cases and Practical Tips

Management of Constipation in Children

Inhaler Devices – Common User Errors

expert
Endocrinologist; Dept of Medicine and Endocrinology, Austin Health, University of Melbourne; Editor, Progress in Osteoporosis